Vairavan Latha 4
4 · Arcutis Biotherapeutics, Inc. · Filed May 7, 2025
Insider Transaction Report
Form 4
Vairavan Latha
SVP Chief Financial Officer
Transactions
- Award
Common Stock
2025-05-06+20,000→ 65,104 total - Award
Stock Option (right to buy)
2025-05-06+60,000→ 60,000 totalExercise: $14.32Exp: 2035-05-06→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest as to 25% of the RSUs on each annual anniversary of May 1, 2025 (the "Vesting Commencement Date"), beginning on May 1, 2026, subject to the Reporting Person's continued service through the vesting date.
- [F2]The options will vest and become exercisable as to 1/48th of the shares on each monthly anniversary of May 6, 2025 (the "Vesting Commencement Date"), subject to the Reporting Person's continued service through the applicable vesting date.